Previous study suggests that ZNF165 is specifically expressed in the testis and tumor tissues and involved in the development of various malignant tumors, such as breast cancer [8], urinary bladder cancer [6], and hepatocellular carcinoma patients [3, 9]. This evidence concerns the gene ZNF165 and urinary bladder cancer.